Glimblist-PM 1 Tablet ER

Short Description

Glimblist-PM 1 Tablet ER is a combination medicine used to control blood sugar levels in adults with type 2 diabetes mellitus.

Dosage Form

Tablet ER

Introduction

Glimblist-PM 1 Tablet ER is a combination medicine that helps control blood sugar levels in adults with type 2 diabetes mellitus. It is used together with diet and exercise to improve blood sugar control. The medicine helps in the proper utilization of insulin, thereby lowering blood sugar levels. It is important to follow the prescribed dosage and be aware of potential side effects and warnings, especially related to pregnancy, breastfeeding, and alcohol consumption.

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Glimblist-PM 1 Tablet ER is to be taken with food.

Glimblist-PM 1 Tablet ER is a combination of three antidiabetic medicines: Glimepiride, Metformin, and Pioglitazone. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glimepiride increases the amount of insulin released by the pancreas. Metformin lowers glucose production in the liver, delays glucose absorption from the intestines, and increases the body's sensitivity to insulin. Pioglitazone further increases insulin sensitivity.

Take it with food to lower your chance of having an upset stomach. It may cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Always carry some sugary food or fruit juice with you in case you experience hypoglycemic symptoms such as cold sweats, cool pale skin, tremor, and anxiety. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).